摘要
肝癌是我国常见的恶性肿瘤,其治疗效果差,预后差,中西医结合治疗成为当前肝癌治疗的重要选择。槐耳作为一种常用的抗癌中成药,广泛用于肝癌的治疗,获得了较好的临床疗效,基础研究提示槐耳通过多途径发挥抗肿瘤作用。故本文对槐耳治疗肝癌的基础和临床研究现状进行综述,以期促进槐耳在肝癌治疗中的应用。
Primary liver cancer is a common malignancy in China with poor treatment outcomes and prognosis.At present,for the treatment of primary liver cancer,integrated Chinese and western medicine serves as an important option.As a common anti-cancer Chinese patent medicine,Huaier(槐耳)is widely used for liver cancer with good efficacy.Basic research has suggested that the anti-tumor effect of Huaier(槐耳)is achieved through multiple pathways.The present study reviewed the basic and clinical research on Huaier(槐耳)in the treatment of liver cancer to promote its clinical application.
作者
李华伟
游佳
张涛
Li Huawei;You Jia;Zhang Tao(Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072;School of Chinese Classics,Chengdu University of Traditional Chinese Medicine,Chengdu 611137)
出处
《中药药理与临床》
CAS
CSCD
北大核心
2022年第1期224-229,共6页
Pharmacology and Clinics of Chinese Materia Medica
关键词
槐耳
肝癌
研究进展
Huaier(槐耳)
liver cancer
research progress
